Obesity linked to prostate cancer risk: New study uncovers inherited dangers from fathers

Obesity contributes to prostate cancer risk and can be inherited from obese fathers, as shown in a review of over 280 studies examining obesity’s impact on carcinogenesis and heritability.

Pembrolizumab combination therapies effective for advanced NSCLC, study shows

While pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this therapy. Treatment failure,

July 13, 2023

Schrödinger takes a step forward with AlphaFold in drug R&D, as biotech hits a pipeline ‘inflection’

Schrödinger has workshopped a fix for one of the biggest problems with AlphaFold-generated protein structure predictions, in what the company is describing as a notable

February 2, 2024

Meta Title: “Axsome Therapeutics Inc Files Patent for Treating Narcolepsy with Cataplexy Using Reboxetine

According to GlobalData’s company profile on Axsome Therapeutics, Antibody-conjugate nanoparticles was a key innovation area identified from patents. Axsome Therapeutics‘s grant share as of January

April 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.